Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 11-17 of 17 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantationKumar, S.; Perez, W.; Zhang, M.; Ballen, K.; Bashey, A.; To, L.; Bredeson, C.; Cairo, M.; Elfenbein, G.; Freytes, C.; Gale, R.; Gibson, J.; Kyle, R.; Lacy, M.; Lazarus, H.; McCarthy, P.; Milone, G.; Moreb, J.; Pavlovsky, S.; Reece, D.; et al.
2011Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX Trial of capecitabine alone or in combination with Bevacizumab and Mitomycin in advanced colorectal cancerPrice, T.; Hardingham, J.; Lee, C.; Weickhardt, A.; Townsend, A.; Wrin, J.; Chua, A.; Shivasami, A.; Cummins, M.; Murone, C.; Tebbutt, N.
1997The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive statusNeed, A.; Morris, H.; Horowitz, M.; Nordin, B.
2010CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: Expanded polymorphism coverage improves risk stratificationSchroth, W.; Hamann, U.; Fasching, P.; Dauser, S.; Winter, S.; Eichelbaum, M.; Schwab, M.; Brauch, H.
2012The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciaticaSumracki, N.; Hutchinson, M.; Gentgall, M.; Briggs, N.; Williams, D.; Rolan, P.; Ikeda, K.
2016Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ARTLambert-Niclot, S.; George, E.; Pozniak, A.; White, E.; Schwimmer, C.; Jessen, H.; Johnson, M.; Dunn, D.; Perno, C.; Clotet, B.; Plettenberg, A.; Blaxhult, A.; Palmisano, L.; Wittkop, L.; Calvez, V.; Marcelin, A.; Raffi, F.; Dedes, N.; Chěne, G.; Allavena, C.; et al.
2013L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trialRalph, A.; Waramori, G.; Pontororing, G.; Kenangalem, E.; Wiguna, A.; Tjitra, E.; Sandjaja,; Lolong, D.; Yeo, T.; Chatfield, M.; Soemanto, R.; Bastian, I.; Lumb, R.; Maguire, G.; Eisman, J.; Price, R.; Morris, P.; Kelly, P.; Anstey, N.; von Seidlein, L.